Just four months after its inauguration, the Head & Neck Cancer Institute of India (HNCII) is making rapid strides as it attempts to take on the challenge posed by the rise of head and neck cancers in India.
HNCII’s inception was driven by this urgent need. Under the leadership of its director Prathamesh Pai — a renowned cancer surgeon who once trained under Pradhan — HNCII has carried out 600 treatment procedures and 5,000 patient consultations to date.
The institute aims to focus not only on treating the disease but also prioritizes the overall well-being and quality of life of its patients. This approach is particularly vital given the complex nature of head and neck cancers, which can significantly impact patients’ daily lives.
The occupancy rate of HNCII, which has reached around 50%, highlights the acute demand for specialized cancer care.
HNCII also plans to expand its services, incorporating cutting-edge technology and treatments, and building out its facilities at two plots earmarked for further development.
Pradhan and Pai emphasise the importance of early detection in cancer treatment. They note that many patients present at advanced stages, making treatment more challenging. The institute’s leadership underscores the need for healthier lifestyles to combat tobacco-related cancers, a significant issue in India.
With a pedigreed leadership, a dedicated medical team, and a focus on affordability and prevention, HNCII aims to become a premier institute in the country offering cancer care. For Dr Pradhan, the need for prevention and early intervention is of utmost importance. His clarion call: “Don’t Wait, Come Early and Get Treated Early.”
link